Table 3: Survival estimates by the Kaplan-Meier method.

Variable

Mean ± SD,

months

95% CI

Survival

at one year

(%)

Five-year

survival

(%)

p

Body mass index

< 22.06

> 22.06

 

16.00 ± 10.53

47.43 ± 12.2

 

0-36.65

23.51-71.35

 

34.17

64.70

 

NR

48.55

 

0.2

Type 2

diabetes mellitus

No

Yes

 

 

44.50 ± 15.66

23.31 ± 5.7

 

 

13.79-75.2

12.13-34.49

 

 

66.45

53.33

 

 

44.40

NR

 

 

0.73

 

Arterial

hypertension

No

Yes

 

 

41.94 ± 13.7

14.31 ± 3.22

 

 

15.08-68.80

8-20.63

 

 

83.30

56.14

 

 

27.78

NR

 

 

0.28

Viral hepatitis

No

Yes

 

37.93 ± 13.00

26.16 ± 7.69

 

12.43-63.42

11.08-41.24

 

66.66

66.67

 

35.56

NR

 

0.91

Liver cirrhosis

No

Yes

 

15.66 ± 4.04

33.83 ± 10.07

 

7.74-23.59

14.09-53.57

 

67.50

66.10

 

33.75

NR

 

0.82

Lesion size

< 5 cm

> 5 cm

 

21.75 ± 6.08

51.42 ± 14.03

 

9.83-33.66

23.92-78.92

 

53.57

71.43

 

NR

53.57

 

0.25

OKUDA

I

II

 

40.42 ± 11.82

14.16 ± 4.05

 

17.25-63.59

6.21-22.12

 

72.92

50.00

 

27.34

NR

 

0.43

Alpha fetoprotein

< 200

> 200

 

34.37 ± 11.2

14.25 ± 4.95

 

12.40-56.34

4.53-23.96

 

60.61

50.00

 

22.73

NR

 

0.68

Sorafenib

No

Yes

 

20.00 ± 3.68

38.04 ± 12.45

 

12.78-27.21

13.63-62.44

 

66.45

58.74

 

NR

29.37

 

0.93

OKUDA I no positive criteria, II one or two positive,

SD = standard deviation,

NR = not recorded.